[Stabilizing effect of anti-inflammatory drugs on erythrocyte membrane. I. On hemolysis and lipid peroxidation induced by H202 in canine erythrocyte].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001623:Betamethasone / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects*; D002738:Chloroquine / Q000494:pharmacology; D004285:Dogs; D004912:Erythrocytes / Q000187:drug effects*; D005439:Flufenamic Acid / Q000494:pharmacology; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008528:Mefenamic Acid / Q000494:pharmacology; D010113:Oxyphenbutazone / Q000494:pharmacology; D010545:Peroxides / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D010545:Peroxides; D012459:Salicylates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D002738:Chloroquine; D001623:Betamethasone; D011239:Prednisolone; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin